Cancer
Malignant Liver Neoplasm
CI-CAN-00003177Explore in graph →
Top-level908 active trials14 approved drugs17 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00003177Explore in graph →
Clinical trials
4,126 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (460)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03594929 | Effect of Remote Ischaemic preConditioning on Liver Injury in Patients Undergoing LIVER Resection Surgery | unknown | N/A | 50 | Singapore General HospitalOTHER | 1 | Jul 20, 2018 | clinicaltrials |
| NCT03585166 | Nursing Fro Laparoscopic vs. Open Hepatectomy | unknown | — | 200 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Jul 12, 2018 |
| clinicaltrials |
| NCT02678806 | Radiotherapy in Hepatocellular Carcinomas After Hepatectomy With Narrow Margin (<1 cm) and / or Microvascular Invasion(RHCC:BCLC-A) | unknown | N/A | 620 | Guangxi Medical UniversityOTHER | 1 | Jul 10, 2018 | clinicaltrials |
| NCT03129685 | Ipsilateral Liver Lobe Devascularization of the Large Hepatocellular Carcinoma(NRU) | unknown | N/A | 12 | The National Ribat UniversityOTHER | 1 | Jun 12, 2018 | clinicaltrials |
| NCT03551444 | Recurrence Rate of Hepatocellular Carcinoma After Treatment of Chronic Hepatits C Patients With Direct Acting Antivirals: Randomized Controlled Phase 3 Trial(CAUTIOUS) | unknown | Phase 3 | 80 | Ain Shams UniversityOTHER | 1 | Jun 11, 2018 | clinicaltrials |
| NCT01681446 | Adjuvant IFN-α for Patients Underwent Curative Surgery for HCC With a Low miR-26 Expression | unknown | Phase 3 | 296 | Fudan UniversityOTHER | 1 | Jun 1, 2018 | clinicaltrials |
| NCT01834963 | P2 Study of Postoperative Interferon/Fluorouracil vs Cisplatin/Fluorouracil for Hepatocellular Carcinoma. | unknown | Phase 2 | 66 | Kansai Hepatobiliary Oncology GroupNETWORK | 1 | May 18, 2018 | clinicaltrials |
| NCT03521219 | A Study of Second-line Treatment With Apatinib for Advanced Intrahepatic Cholangiocarcinoma | unknown | Phase 2 | 30 | The First Affiliated Hospital of Zhengzhou UniversityOTHER | 1 | May 11, 2018 | clinicaltrials |
| NCT03520257 | The Study of Apatinib Plus Radiotherapy vs. Apatinib in the Treatment of Hepatocellular Carcinoma With BCLC-C Stage I and Stage II Portal Vein Tumor Thrombus | unknown | Phase 2 | 50 | Guangxi Medical UniversityOTHER | 0 | May 9, 2018 | clinicaltrials |
| NCT03518502 | Sorafenib Monotherapy vs. TACE-sorafenib Sequential Therapy for HCC With Metastasis | unknown | Phase 4 | 130 | Korea UniversityOTHER | 1 | May 8, 2018 | clinicaltrials |
| NCT03516448 | Expanding Phase III Study of Tyroserleutide for Injection | unknown | Phase 3 | 352 | Shenzhen Kangzhe Pharmaceutical Co., Ltd.INDUSTRY | 0 | May 4, 2018 | clinicaltrials |
| NCT03515369 | Effect of Babaodan on Tumor Recurrence After Curative Resection of Hepatocellular Carcinoma | unknown | Phase 4 | 459 | Eastern Hepatobiliary Surgery HospitalOTHER | 0 | May 3, 2018 | clinicaltrials |
| NCT03285867 | Liver Stiffness Measurement (LSM) in Predicting Progress of Liver Fibrosis After TACE for Hepatocellular Carcinoma | unknown | — | 200 | Nanfang Hospital, Southern Medical UniversityOTHER | 0 | Apr 30, 2018 | clinicaltrials |
| NCT03511703 | The Study of The Treatment of Postoperative Adjuvant Apatinib vs. TACE in Hepatocellular Carcinoma Patients | unknown | Phase 2 | 40 | Guangxi Medical UniversityOTHER | 0 | Apr 30, 2018 | clinicaltrials |
| NCT01135056 | Study to Compare Selective Internal Radiation Therapy (SIRT) Versus Sorafenib in Locally Advanced Hepatocellular Carcinoma (HCC)(SIRveNIB) | unknown | Phase 3 | 360 | Singapore General HospitalOTHER | 12 | Apr 24, 2018 | clinicaltrials |
| NCT03132740 | Impact of Three-dimensional Visualization on Operation Strategy and Complications for Complex Hepatic Carcinoma | unknown | — | 2,000 | Zhujiang HospitalOTHER | 1 | Apr 19, 2018 | clinicaltrials |
| NCT03191123 | Resection Versus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma With Solitary Huge Tumor | unknown | N/A | 100 | Huazhong University of Science and TechnologyOTHER | 1 | Apr 13, 2018 | clinicaltrials |
| NCT03493763 | Study on Recurrence Monitoring of Hepatocellular Carcinoma With 5-Hydroxymethylcytosine Test | unknown | — | 300 | Shanghai Zhongshan HospitalOTHER | 1 | Apr 10, 2018 | clinicaltrials |
| NCT03468231 | HAIC of FOLFOX vs. HAIC of OXA for Advanced HCC | unknown | Phase 3 | 300 | Sun Yat-sen UniversityOTHER | 1 | Mar 16, 2018 | clinicaltrials |
| NCT01719835 | CHOP vs GEM-P in 1st Line Treatment of T-cell Lymphoma, Multicentre Phase II Study(CHEMO-T) | unknown | Phase 2 | 87 | Royal Marsden NHS Foundation TrustOTHER | 1 | Mar 15, 2018 | clinicaltrials |
| NCT02942329 | Exploratory Clinical Study of Apatinib and SHR-1210 in Treating Advanced Hepatocellular Carcinoma or Gastric Cancer | unknown | Phase 1 / Phase 2 | 60 | The Affiliated Hospital of the Chinese Academy of Military Medical SciencesOTHER | 1 | Feb 26, 2018 | clinicaltrials |
| NCT03416803 | A Study of Individualized Radiotherapy Based on a Prediction Model of Lymph Node Metastasis in Hepatocellular Carcinoma | unknown | N/A | 150 | Shanghai Zhongshan HospitalOTHER | 1 | Feb 5, 2018 | clinicaltrials |
| NCT01850316 | Hepatocellular Carcinoma Using Stereotactic Body Radiotherapy | unknown | N/A | 13 | British Columbia Cancer AgencyOTHER | 1 | Jan 18, 2018 | clinicaltrials |
| NCT03175705 | Adoptive Transfer of Specific HCC Antigens CD8+ T Cells for Treating Patients With Relapsed/Advanced HCC | unknown | Phase 1 | 18 | Beijing YouAn HospitalOTHER | 1 | Jan 18, 2018 | clinicaltrials |
| NCT02525380 | Safety and Efficacy of Doxorubicin-eluting-bead Embolization in Patients With Advanced Hepatocellular Carcinoma | unknown | Phase 4 | 30 | Seoul National University HospitalOTHER | 1 | Jan 17, 2018 | clinicaltrials |
| NCT03398122 | Study of Apatinib Combined With TACE in Advance Hepatocellular Carcinoma(HCC) | unknown | N/A | 248 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Jan 12, 2018 | clinicaltrials |
| NCT02646137 | Single Session Combined Locoregional Therapies for Hepatocellular Carcinoma | unknown | Phase 3 | 50 | Sherief Abd-ElsalamOTHER | 1 | Jan 9, 2018 | clinicaltrials |
| NCT02461979 | The Role of the Vitamin D Receptor Gene Polymorphisms in Hepatocarcinogenesis | unknown | N/A | 50 | Sherief Abd-ElsalamOTHER | 1 | Jan 3, 2018 | clinicaltrials |
| NCT02311205 | Efficacy and Safety of Concurrent TACE and Sorafenib in Patients With HCC and Extrahepatic Metastasis (COTSOM Study)(COTSOM) | unknown | Phase 2 | 55 | Asan Medical CenterOTHER | 1 | Dec 18, 2017 | clinicaltrials |
| NCT03345303 | Bortezomib in Intrahepatic Cholangiocellular Carcinoma | unknown | Phase 3 | 50 | Zhengang YuanOTHER | 1 | Nov 17, 2017 | clinicaltrials |
| NCT01746992 | CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma | unknown | Phase 4 | 200 | Ruijin HospitalOTHER | 1 | Nov 14, 2017 | clinicaltrials |
| NCT03340636 | Residual Plasma Concentration of Sorafenib and Adverse Events in CHC(PharmacoCHC) | unknown | — | 60 | University Hospital, CaenOTHER | 1 | Nov 13, 2017 | clinicaltrials |
| NCT03166683 | Standard of Care Versus Hemopatch® During Liver Resection(IBERLIVER) | unknown | N/A | 284 | Fundación Pública Andaluza para la gestión de la Investigación en SevillaOTHER | 0 | Nov 9, 2017 | clinicaltrials |
| NCT03337841 | Pembrolizumab as Neoadjuvant Treatment in HCC | unknown | Phase 2 | 50 | Kindai UniversityOTHER | 0 | Nov 9, 2017 | clinicaltrials |
| NCT03338166 | Role of LDH as a Predictor of Treatment Outcomes in Hepatocellular Carcinoma | unknown | — | 50 | Assiut UniversityOTHER | 0 | Nov 9, 2017 | clinicaltrials |
| NCT01217034 | Transcatheter Arterial Chemoembolization Therapy In Combination With Sorafenib(TACTICS) | unknown | Phase 2 | 228 | Kindai UniversityOTHER | 1 | Oct 31, 2017 | clinicaltrials |
| NCT03326375 | Comparison of SBRTand Repeat TACE for HCC(STH) | unknown | N/A | 80 | Gangneung Asan HospitalOTHER | 1 | Oct 31, 2017 | clinicaltrials |
| NCT03323996 | Impact of a Training in Therapeutic Education on the Relation Between Care Givers and Their Patients(METIS) | unknown | — | 40 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Oct 27, 2017 | clinicaltrials |
| NCT03314532 | The Efficacy of Hepatectomy or TILA-TACE in Patients With Resectable Hepatocellular Carcinoma | unknown | N/A | 230 | Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER | 1 | Oct 19, 2017 | clinicaltrials |
| NCT03297255 | Primary Liver Cancer Cohort of South China | unknown | — | 4,000 | Huilian ZhuOTHER | 1 | Sep 29, 2017 | clinicaltrials |
| NCT03292991 | REgistry of Selective Internal Radiation Therapy in TaiwaN (RESIN) | unknown | — | 100 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Sep 26, 2017 | clinicaltrials |
| NCT03235167 | Cytidine-phosphate-guanosine (CpG) DNA in Hepatocellular Carcinoma Combination Therapy | unknown | Phase 1 | 100 | Dalian UniversityOTHER | 0 | Sep 18, 2017 | clinicaltrials |
| NCT02830737 | No-touch RFA Versus Traditional RFA for Small Hepatocellular Carcinoma | unknown | N/A | 178 | Southwest Hospital, ChinaOTHER | 1 | Sep 15, 2017 | clinicaltrials |
| NCT03083002 | Risk of Hepatocellular Carcinoma in Patient With Liver Cirrhosis | unknown | — | 250 | University of Modena and Reggio EmiliaOTHER | 1 | Sep 13, 2017 | clinicaltrials |
| NCT03273608 | Observation Study: Superselective Drug-Eluting Chemoembolization in Unresectable Intermediate and Advanced HCC Patients | unknown | — | 120 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Sep 6, 2017 | clinicaltrials |
| NCT03261791 | Adjuvant Therapy With Apatinib for HCC Patients With PVTT Who Underwent Radical Resection | unknown | Phase 2 | 30 | Shanghai Zhongshan HospitalOTHER | 1 | Aug 25, 2017 | clinicaltrials |
| NCT02767375 | Hepatic Arterial Infusion Chemotherapy(HAIC) for Hepatoma After Resection(HAICAT) | unknown | Phase 2 / Phase 3 | 192 | Peking University Cancer Hospital & InstituteOTHER | 1 | Aug 10, 2017 | clinicaltrials |
| NCT03243916 | Targeted and Staged Cyber Knife Combined With Interventional Therapy in the Treatment of MHCC | unknown | N/A | 40 | Chinese PLA General HospitalOTHER | 1 | Aug 9, 2017 | clinicaltrials |
| NCT03227510 | MicroRNAs as Diagnostic Biomarkers in Hepatocellular Carcinoma Among Somali Patients | unknown | — | 126 | People's Friendship University of RussiaOTHER | 0 | Jul 25, 2017 | clinicaltrials |
| NCT03208335 | Recombinant Human Endostatin(Rh-endostatin) Combine With Radiotherapy in the Treatment of Hepatocellular Carcinoma(HCC) | unknown | Phase 2 | 61 | Chinese PLA General HospitalOTHER | 1 | Jul 5, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Jul 20, 2018source: clinicaltrials